Skip to content

Precigen PGEN Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
Gilead Sciences logo
Gilead SciencesGILD
5.3%+1.1pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-18%-4.7pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-21.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-4.4%-1.5pp

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Based on trailing twelve months.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's earnings yield?
Precigen (PGEN) reported earnings yield of -14.9% in Q1 2026.
How has Precigen's earnings yield changed year-over-year?
Precigen's earnings yield increased by 58.3% year-over-year, from -35.8% to -14.9%.
What is the long-term trend for Precigen's earnings yield?
Over 4 years (2020 to 2025), Precigen's earnings yield has grown at a 18.3% compound annual growth rate (CAGR), from -8.6% to -16.9%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.